Withholding of Life-sustaining Treatment and Quality of Life After Severe Acute Brain Injury: Qualitative Analysis and Ethical Issues

Recruiting Observational Study
Quality of Life Brain Injuries Post ICU
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
14 (estimated)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Withdrawal of life-sustaining treatment affects 10-15% of ICU patients, including those with severe acute brain injury, whose care appears futile in terms of prognosis based on clinical and paraclinical data, expected quality of life, patient preferences, age, or reduced quality of life. There are few studies on withholding treatment compared with withdrawing treatment, and even fewer on survivor…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Patients: * with severe acute brain injury (TBI, stroke, central nervous system infection). * admitted in the neurocritical care unit in 2022. * followed up 24 months after ICU between 15th April 2024 and 31st August 2024. Exclusion Criteria: Patients: * death in 2024, * ref…
Contacts

Marie DAKENG, resident

(0)4 77 82 83 29

mcgperret@gmail.com

CONTACT

Nory ELHADJENE, MD

(0)4 77 82 83 29

Nory.ELHADJENE@chu-st-etienne.fr

CONTACT